GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.970
+0.020 (0.51%)
May 20, 2025, 4:00 PM - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for GoodRx Holdings stock ranges from a low of $5.00 to a high of $16. The average analyst price target of $7.75 forecasts a 95.21% increase in the stock price over the next year.
Price Target: $7.75 (+95.21%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 9 | 9 | 8 | 8 | 6 | 6 |
| Hold | 4 | 4 | 4 | 4 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 14 | 14 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $6 → $5.25 | Hold | Maintains | $6 → $5.25 | +32.24% | May 13, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +25.94% | May 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +76.32% | Apr 29, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $6.5 → $5.5 | Hold | Maintains | $6.5 → $5.5 | +38.54% | Apr 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +101.51% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
836.70M
from 792.32M
Increased by 5.60%
Revenue Next Year
882.23M
from 836.70M
Increased by 5.44%
EPS This Year
0.40
from 0.04
Increased by 890.42%
EPS Next Year
0.47
from 0.40
Increased by 18.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 872.5M | 941.1M | 1.0B | ||
| Avg | 836.7M | 882.2M | 946.1M | ||
| Low | 798.1M | 817.6M | 859.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.1% | 12.5% | 15.7% | ||
| Avg | 5.6% | 5.4% | 7.2% | ||
| Low | 0.7% | -2.3% | -2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.45 | 0.53 | 0.58 | ||
| Avg | 0.40 | 0.47 | 0.53 | ||
| Low | 0.34 | 0.40 | 0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1,028.8% | 32.5% | 23.0% | ||
| Avg | 890.4% | 18.5% | 13.2% | ||
| Low | 757.5% | 1.4% | 1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.